PTSM: Pharmaceutical Technology Sourcing and Management, Apr 3, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 3, 2013
Global Feature
Indian Supreme Court Rejects Patent for Glivec by Novartis
By Patricia Van Arnum
Ruling has implications for intellectual property protection for innovator drugs in India.
The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company
By Patricia Van Arnum
Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Outsourcing
Outsourcing of Non-traditional Protein Expression Systems Increases
By Eric Langer
A recent study shows growth in outsourcing of insect- and plant-cell-based bioproduction expression systems.
CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations
GlaxoSmithKline Tops Industry Rankings for Access to Medicines
By Patricia Van Arnum
The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here